Watch a webinar by Prof. Fred Witjes
On Thursday 24 September 2020, Nucleix, Israel and Oncotest-Rhenium, Israel organised the webinar “Follow-up of NMIBC, Including the Place of Urinary Markers”. The webinar included 45 minutes lecture by Prof. Dr. Fred Witjes, Professor of oncological urology at Radboud UMC Nijmegen, the Netherlands and 15 minutes Q&A, and was chaired by Dr. Dov Engelstein, Chairman of the Israel Association of Urology (IAU), and Dr. Ran Katz, Associate in the Israel Association of Urology (IAU).
- The current guidelines on treatment and follow-up of Non Muscle-Invasive Bladder Cancer (NMIBC)
- The pitfalls of the current follow-up procedures
- Urinary markers in follow-up and promising results from clinical studies
- The benefits of urinary markers in general and during the COVID-19 pandemic
Moreover, Prof. Dr. Fred Witjes provided insights on how he implements the Bladder EpiCheck® urine test in his clinical practice.